High-flow nasal oxygen therapy showed no benefit after cardiac surgery in a major trial. Learn more about the study.
Robot vacuum releases for 2026 kicked off in February and have been relentless since. Compared to multiple pre-spring release ...
Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its All Patient ...
Findings from the AltaValve Early Feasibility Study suggest that patients with a leaky mitral valve have sustained clinical ...
A new sub-study suggests that using a sirolimus-eluting balloon (SEB), a drug-coated balloon, can reduce the number of stents ...
House of Investments Inc. Annual cash flow by MarketWatch. View HI net cash flow, operating cash flow, operating expenses and cash dividends.
Introduction Reduced exercise performance is common in patients with repaired tetralogy of Fallot (rToF) and relates to ...
Routine high-flow nasal oxygen therapy (HFNOT) following extubation did not improve outcomes compared to standard oxygen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results